| A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics N Gökhan-Kelekçi, S Yabanoğlu, E Küpeli, U Salgın, Ö Özgen, G Uçar, ... Bioorganic & medicinal chemistry 15 (17), 5775-5786, 2007 | 314 | 2007 |
| New pyrazoline bearing 4 (3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity N Gökhan-Kelekçi, S Koyunoğlu, S Yabanoğlu, K Yelekçi, Ö Özgen, ... Bioorganic & medicinal chemistry 17 (2), 675-689, 2009 | 187 | 2009 |
| The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis N Şengül, S Işık, B Aslım, G Uçar, AE Demirbağ Digestive diseases and sciences 56, 707-714, 2011 | 126 | 2011 |
| 1‐N‐Substituted Thiocarbamoyl‐3‐phenyl‐5‐thienyl‐2‐pyrazolines: Synthesis and Evaluation as MAO Inhibitors N Gökhan, A Yeşilada, G Uçar, K Erol, AA Bilgin Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003 | 117 | 2003 |
| 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: A novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and … G Ucar, N Gokhan, A Yesilada, AA Bilgin Neuroscience letters 382 (3), 327-331, 2005 | 112 | 2005 |
| Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies B Mathew, GE Mathew, G Uçar, I Baysal, J Suresh, JK Vilapurathu, ... Bioorganic Chemistry 62, 22-29, 2015 | 88 | 2015 |
| Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro I Baysal, G Ucar, M Gultekinoglu, K Ulubayram, S Yabanoglu-Ciftci Journal of neural transmission 124, 33-45, 2017 | 85 | 2017 |
| Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies A Sahoo, S Yabanoglu, BN Sinha, G Ucar, A Basu, V Jayaprakash Bioorganic & medicinal chemistry letters 20 (1), 132-136, 2010 | 85 | 2010 |
| Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats N Şengül, B Aslím, G Uçar, N Yücel, S Işık, H Bozkurt, Z Sakaoğullarí, ... Diseases of the colon & rectum 49, 250-258, 2006 | 81 | 2006 |
| Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors B Mathew, A Haridas, G Uçar, I Baysal, AA Adeniyi, MES Soliman, M Joy, ... International journal of biological macromolecules 91, 680-695, 2016 | 76 | 2016 |
| Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: A new class of reversible MAO‐B inhibitors B Mathew, A Haridas, G Uçar, I Baysal, M Joy, GE Mathew, ... ChemMedChem 11 (11), 1161-1171, 2016 | 75 | 2016 |
| Identification of Indole‐Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO‐B Inhibitors R Sasidharan, SL Manju, G Uçar, I Baysal, B Mathew Archiv der Pharmazie 349 (8), 627-637, 2016 | 73 | 2016 |
| Monoamine oxidase inhibitory activity of novel pyrazoline analogues: Curcumin based design and synthesis VN Badavath, I Baysal, G Ucar, BN Sinha, V Jayaprakash ACS Medicinal Chemistry Letters 7 (1), 56-61, 2016 | 70 | 2016 |
| Monoamine oxidase inhibitory activity of 3, 5-biaryl-4, 5-dihydro-1H-pyrazole-1-carboxylate derivatives BV Nayak, S Ciftci-Yabanoglu, SS Jadav, M Jagrat, BN Sinha, G Ucar, ... European journal of medicinal chemistry 69, 762-767, 2013 | 69 | 2013 |
| Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies M Karuppasamy, M Mahapatra, S Yabanoglu, G Ucar, BN Sinha, A Basu, ... Bioorganic & medicinal chemistry 18 (5), 1875-1881, 2010 | 67 | 2010 |
| Pharmacological protection against ischemia-reperfusion injury by regulating the Nrf2-Keap1-ARE signaling pathway BI Ucar, G Ucar, S Saha, B Buttari, E Profumo, L Saso Antioxidants 10 (6), 823, 2021 | 65 | 2021 |
| Synthesis of some novel hydrazone and 2-pyrazoline derivatives: Monoamine oxidase inhibitory activities and docking studies B Evranos-Aksöz, S Yabanoğlu-Çiftçi, G Uçar, K Yelekçi, R Ertan Bioorganic & medicinal chemistry letters 24 (15), 3278-3284, 2014 | 64 | 2014 |
| Monoamine oxidase inhibitory activity of methoxy-substituted chalcones B Mathew, GE Mathew, G Ucar, M Joy, EK Nafna, KK Lohidakshan, ... International journal of biological macromolecules 104, 1321-1329, 2017 | 63 | 2017 |
| Pyrazoline-based mycobactin analogues as MAO-inhibitors V Jayaprakash, BN Sinha, G Ucar, A Ercan Bioorganic & medicinal chemistry letters 18 (24), 6362-6368, 2008 | 63 | 2008 |
| Monoamine oxidase inhibitory action of chalcones: A mini review B Mathew, A Haridas, J Suresh, G E Mathew, G Uçar, V Jayaprakash Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2016 | 61 | 2016 |
